Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation

NCT03627884 is registered in ClinicalTrials.gov with Coney Island Hospital, Brooklyn, NY as lead sponsor.

NCT NCT03627884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03627884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation
Lead sponsor
Coney Island Hospital, Brooklyn, NY
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2016
Completion date
March 30, 2018
Enrollment
451 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute renal failure, end stage renal disease, hemodialysis access failure, hemodialysis catheter infection, hemodialysis catheter-associated bacteremia, hemodialysis complication